Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-16

FDA Approved: ARIMIDEX — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ARIMIDEX (anastrozole) filed by ANI Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIMIDEX (anastrozole)

Snippet

SUPPL AP for ARIMIDEX (ANASTROZOLE)